Sat Kartar Life Limited Share Price & Stock Analysis

Sat Kartar Life Limited (NSE: SATKARTAR) is a New Delhi, Delhi-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹256 Cr, it ranks #2,445 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 9 in Non-Prescription Drugs. The share price was ₹170.90 as of 16 Nov 2026.

Key Metrics

Current Price₹170.90
Market Cap₹256 Cr
NSE SymbolSATKARTAR
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Non-Prescription Drugs
P/E Ratio15.7
Return on Equity25.30%
Return on Assets17.82%
Beta (1Y)0.71
Dividend Yield0.41%
HeadquartersNew Delhi, Delhi
Websitewww.satkartar.in

Shareholding and Delivery

Promoters held 63.49% of Sat Kartar Life Limited's shares as of Sept 2026, against 63.43% in Sept 2025 (+0.06 percentage points).

About Sat Kartar Life Limited

Sat Kartar Life Limited, an ayurvedic healthcare company, provides ayurvedic products in India. The company offers ayurvedic products, vitamins, supplements, and herbal products for various health conditions, including piles, diabetes, sexual health, stamina booster, immunity booster, infertility, joint pain, hair care, addiction care, and respiratory health solutions. It also sells its products through online. The company was formerly known as Sat Kartar Shopping Limited and change its name to Sat Kartar Life Limited in February 2026. The company was incorporated in 2012 and is based in New Delhi, India.

Products and Services

1. Herbal Products-This segment offers ayurvedic products related to personal wellness of men and women; and products related to address various diseases, such diabetes, addiction, joint pain, low immunity, and others. 2. NA-NA 3. NA-NA 4. NA-NA

Sat Kartar Life Limited vs Peers — Non-Prescription Drugs

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Glaxosmithkline Pharmaceuticals Ltd.₹44,982 Cr43.448.91%₹1,184 Cr+3.3%
Alembic Pharmaceuticals Limited (Aplltd)₹20,245 Cr30.512.36%₹2,603 Cr+11.7%
Bliss Gvs Pharma Ltd.₹6,817 Cr53.911.60%₹313 Cr+426.3%
Zota Health Care Ltd₹4,585 Crn/m-16.05%₹199 Cr-15.1%
Amrutanjan Health Care Ltd.₹1,467 Cr25.316.62%₹135 Cr-28.1%
Jenburkt Pharmaceuticals Ltd.₹433 Cr12.518.84%—-11.8%
Sat Kartar Life Limited₹256 Cr15.725.30%——
Vista Pharmaceuticals Ltd.₹40 Crn/m-10.82%—-37.1%
Welcure Drugs & Pharmaceuticals₹23 Crn/m-5.50%—-64.2%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Sat Kartar Life Limited?

Sat Kartar Life Limited is trading at ₹170.90, with a market capitalisation of ₹256 Cr.

Which sector does Sat Kartar Life Limited belong to?

Sat Kartar Life Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).

What are the key financial ratios of Sat Kartar Life Limited?

Sat Kartar Life Limited has a P/E of 15.7 and a return on equity of 25.30%.

What is the stock symbol of Sat Kartar Life Limited?

Sat Kartar Life Limited is listed on the NSE under the symbol SATKARTAR.

What is the promoter holding in Sat Kartar Life Limited?

Promoters held 63.49% of Sat Kartar Life Limited's shares as of Sept 2026, against 63.43% in Sept 2025 (+0.06 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.